Matrix Asset Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.8M Sell
426,624
-7,048
-2% -$621K 3.03% 11
2026
Q2
$33.9M Buy
433,672
+57,976
+15% +$4.68M 2.76% 13
2026
Q1
$32.6M Buy
375,696
+6,155
+2% +$590K 2.99% 12
2025
Q4
$35.5M Sell
369,541
-1,068
-0.3% -$104K 3.19% 10
2025
Q3
$35.3M Buy
370,609
+1,428
+0.4% +$131K 3.27% 9
2025
Q2
$32.2M Buy
369,181
+6,929
+2% +$588K 3.26% 8
2025
Q1
$32.6M Buy
362,252
+38,297
+12% +$3.43M 3.59% 5
2024
Q4
$25.9M Buy
323,955
+15,589
+5% +$1.35M 2.83% 13
2024
Q3
$27.8M Buy
308,366
+30,769
+11% +$2.59M 3.09% 11
2024
Q2
$21.8M Buy
277,597
+95,376
+52% +$7.82M 2.61% 14
2024
Q1
$15.9M Buy
182,221
+13,312
+8% +$1.14M 1.9% 20
2023
Q4
$13.9M Buy
168,909
+1,468
+0.9% +$112K 1.77% 21
2023
Q3
$13.1M Buy
167,441
+9,797
+6% +$820K 1.87% 20
2023
Q2
$13.9M Buy
157,644
+2,773
+2% +$239K 1.91% 21
2023
Q1
$12.5M Buy
154,871
+9,401
+6% +$766K 1.81% 23
2022
Q4
$11.3M Sell
145,470
-901
-0.6% -$73K 1.69% 25
2022
Q3
$11.8M Sell
146,371
-29,844
-17% -$2.68M 1.94% 21
2022
Q2
$15.8M Buy
176,215
+56,838
+48% +$5.76M 2.43% 14
2022
Q1
$13.2M Buy
+119,377
New +$12.6M 1.78% 25

Other funds holding MDT

Matrix Asset Advisors's MDT Position: Q3 2026 in Review

Matrix Asset Advisors reduced its Medtronic (MDT) stake by 1.6% in Q3 2026, selling an estimated $621K and leaving 426,624 shares worth $36.8M. The position accounts for 3.03% of the portfolio, ranked #11.

Matrix Asset Advisors first reported a position in MDT in Q1 2022 and has held it in 19 quarters since. 583 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Matrix Asset Advisors held 426,624 shares of Medtronic worth $36.8M as of Q3 2026.
  • Matrix Asset Advisors sold 7,048 Medtronic shares in Q3 2026, an estimated $621K.
  • Medtronic made up 3.03% of Matrix Asset Advisors's portfolio in Q3 2026, its #11 holding.
  • Matrix Asset Advisors first reported a position in Medtronic in Q1 2022 and has held it in 19 quarters since.
  • 583 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Matrix Asset Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.